BIIB

BIIB

Biogen Inc
Biotechnology
$172.97 -2.34% As of Apr 13, 12:58 AM
Loading chart...
Interactive chart powered by TradingView

Technical Analysis

BIIB Coiled Spring Ready to Release at $172.97

Neutral
Apr 13, 2026 at 12:58 AM • $172.97 (-2.34%)

Biogen Inc (BIIB) retreated 2.34%, ending the session at $172.97 on April 13.

The technical setup looks bearish:

Momentum RSI at 40.1 is in neutral territory but trending higher. MACD reads -2.82 against its -1.79 signal line (bearish).
Moving Averages Price sits below both the 9-day ($178.23) and 21-day ($181.44) EMAs, suggesting short-term weakness.
Volatility Stock has been in a TTM Squeeze for 20 days, indicating compressed volatility and potential for a significant move.
Key levels to watch: Support at $172.35, Resistance at $191.54.

Explosive Move Brewing? BIIB Squeezes at $172.97

Neutral
Apr 12, 2026 at 8:08 AM • $172.97 (-2.34%)

Traders Watch BIIB Squeeze Closely at $172.97

Neutral
Apr 11, 2026 at 6:05 AM • $172.97 (-2.34%)

BIIB Volatility Compresses at $172.97, Breakout Watch

Neutral
Apr 10, 2026 at 9:01 PM • $172.97 (-2.34%)

Squeeze Play: BIIB Preps for Breakout at $177.11

Neutral
Apr 9, 2026 at 9:01 PM • $177.11 (-1.56%)
Systematic technical analysis • Updated daily after market close
Exclusive Offer

Get Trade Alerts

Receive disciplined options trade ideas with entries, targets & risk management.

Use code:
HEADSTART50
50% off your first month
Claim Offer Try Scanner

Market Summary

Current Price $172.97
Daily Change -2.34%
Sentiment Neutral
Sector Biotechnology
Last Updated Apr 13

Related Stocks

ABBV
ABBV
AbbVie Inc
AMGN
AMGN
Amgen Inc
MRNA
MRNA
Moderna Inc
REGN
REGN
Regeneron Pharmaceuticals Inc
VRTX
VRTX
Vertex Pharmaceuticals Inc
Disclaimer: This analysis is for educational purposes only. Options trading involves substantial risk. Past performance does not guarantee future results.